Behçet's disease: etiology and treatment

Area of Science:

• Rheumatology and Immunology
• Vascular Medicine

Background:

• Behçet's disease etiology and treatment remain unclear.
• Current understanding involves viral, autoimmune, and fibrinolytic hypotheses.
• Conventional therapy includes corticosteroids, with limited efficacy.

Purpose of the Study:

• To review current etiological hypotheses for Behçet's disease.
• To evaluate the effectiveness of existing therapeutic strategies.
• To highlight the limitations of current treatments.

Main Methods:

• Review of existing literature on Behçet's disease.
• Analysis of proposed etiological factors (viral, autoimmune, fibrinolytic).
• Assessment of outcomes for antiviral, immunosuppressive, and fibrinolytic-enhancing agents.

Main Results:

• No single etiological hypothesis is definitively established.
• Antiviral, immunosuppressive, and fibrinolytic agents have been trialed.
• Corticosteroids are the standard treatment but do not alter disease course.
• Serious complications can arise despite ongoing treatment.

Conclusions:

• Current therapeutic approaches do not fundamentally change Behçet's disease progression.
• Further research is needed to understand the disease's etiology and develop effective treatments.
• Management of Behçet's disease requires careful monitoring for complications.